Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;50(12):1037-44.
doi: 10.1097/MLR.0b013e318269e096.

The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample

Affiliations

The influence of stress, depression, and anxiety on PSA screening rates in a nationally representative sample

Ashwin A Kotwal et al. Med Care. 2012 Dec.

Abstract

Background: Prostate-specific antigen (PSA) testing for prostate cancer is controversial, with concerning rates of both overscreening and underscreening. The reasons for the observed rates of screening are unknown, and few studies have examined the relationship of psychological health to PSA screening rates. Understanding this relationship can help guide interventions to improve informed decision-making for screening.

Methods: A nationally representative sample of men 57-85 years old without prostate cancer (N = 1169) from the National Social life, Health and Aging Project was analyzed. The independent relationship of validated psychological health scales measuring stress, anxiety, and depression to PSA testing rates was assessed using multivariable logistic regression analyses.

Results: PSA screening rates were significantly lower for men with higher perceived stress [odds ratio (OR) = 0.76, P = 0.006], but not for higher depressive symptoms (OR = 0.89, P = 0.22) when accounting for stress. Anxiety influences PSA screening through an interaction with number of doctor visits (P = 0.02). Among the men who visited the doctor once those with higher anxiety were less likely to be screened (OR = 0.65, P = 0.04). Conversely, those who visited the doctor 10+ times with higher anxiety were more likely to be screened (OR = 1.71, P = 0.04).

Conclusions: Perceived stress significantly lowers PSA screening likelihood, and it seems to partly mediate the negative relationship of depression with screening likelihood. Anxiety affects PSA screening rates differently for men with different numbers of doctor visits. Interventions to influence PSA screening rates should recognize the role of the patients' psychological state to improve their likelihood of making informed decisions and improve screening appropriateness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Marginal Probabilities of PSA Screening by selected covariates Model includes age, depression, stress, anxiety, ethnicity, marital status, education, visits to the doctor, and comorbidities Abbreviations: Prostate Specific Antigen – PSA, Standard Deviation - SD
Figure 2
Figure 2
Marginal PSA screening rate by anxiety symptoms and visits to the doctor Model includes age, depression, stress, anxiety, ethnicity, marital status, education, visits to the doctor, and comorbidities

Similar articles

Cited by

References

    1. Ross L, Taylor Y, Richardson L, Howard D. Patterns in Prostate-Specific Antigen Test Use and Digital Rectal Examinations in the Behavioral Risk Factor Surveillance System, 2002–2006. Journal of the National Medical Association. 2009;101(4):317. - PubMed
    1. Walter L, Bertenthal D, Lindquist K, Konety B. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336. - PubMed
    1. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine. 2009;360(13):1320. - PubMed
    1. Andriole GL, Crawford ED, Grubb RL, III, et al. Mortality results from a randomized prostate-cancer screening trial. The New England journal of medicine. 2009;360(13):1310. - PMC - PubMed
    1. Crawford D, Grubb R, III, Black A, et al. Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial. Journal of Clinical Oncology. 2011;29(4):355–361. - PMC - PubMed

Publication types

Substances